The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in severe models of COVID-19.

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Immunology

Paleontology

Pharmacology

Immunosuppression

Show all topics

DOI

10.1101/2024.02.27.582110

License

CC-BY

Other Formats

PDF